pirfenidone has been researched along with Critical Illness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Comes, A; Lerede, M; Richeldi, L; Sgalla, G | 1 |
1 review(s) available for pirfenidone and Critical Illness
| Article | Year |
|---|---|
COVID-related fibrosis: insights into potential drug targets.
Topics: Animals; Antifibrotic Agents; COVID-19; Critical Illness; Humans; Indoles; Pulmonary Fibrosis; Pyridones | 2021 |